Sera Prognostics

Sera Prognostics

Testing for Premature Birth Risk

Human health & social work | United States of America | Health Improvement |

 

Overview

Sera Prognostics is a private biotechnology company developing innovative diagnostic tests designed for the early prediction of preterm birth risk and other pregnancy complications. Sera s tests are designed to help better inform the care of a mother and her unborn child during pregnancy and potentially lead to improved health. The company has assembled a strong management team and Board of Directors with significant clinical development and women s healthcare diagnostic experience.

Industry

Legal Structure

Operating Status

Employees

Human health & social work Operating 51 - 200 employees

Funding and Financing Rounds


Team


Impact

Social Objectives:

Environmental Objectives:

Operational Impact:


Impact Reports & Metrics


Offices

Headquarters

2749 E Parleys Way
Salt Lake City, Utah 84109
United States of America



Explore

Revision History

Last Update: Oct 07, 2017 8:50 p.m.

Quick Search



  • Global  
  • Africa  
  • Americas  
  • Asia  
  • Europe  
  • Oceania  


Incoming

Tags

COPYRIGHT 2024 IMPACTSPACE. ALL RIGHTS RESERVED.